Back to Search
Start Over
Canada Stops Sales of Hyperactivity Drug
- Source :
- The New York Times. February 10, 2005, C4
- Publication Year :
- 2005
-
Abstract
- A subsidiary of the Shire Pharmaceuticals Group of Britain has been asked by Canadian regulators to withdraw its drug Adderall XR amid reports that 14 children and 6 adults taking [...]
- Subjects :
- Shire BioChem Inc. -- Product defects and recalls
Canada. Health Canada -- Investigations
Adderall XR (Medication) -- Product defects and recalls -- Complications and side effects
Drug therapy
Product defects and recalls
Complications and side effects
Investigations
Company legal issue
Attention deficit hyperactivity disorder -- Drug therapy -- Complications and side effects
Biological products industry -- Product defects and recalls
Attention-deficit hyperactivity disorder -- Drug therapy -- Complications and side effects
Subjects
Details
- Language :
- English
- ISSN :
- 03624331
- Database :
- Gale General OneFile
- Journal :
- The New York Times
- Publication Type :
- News
- Accession number :
- edsgcl.128304472